Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy
Cardiac toxicity due to anthracycline therapy is dose related, and congestive failure is a major limiting factor to therapy. Radionuclide cardiac evaluation provides a sensitive noninvasive method for detecting changes in cardiac function. Fifteen patients receiving either doxorubicin or daunomycin...
Gespeichert in:
| Veröffentlicht in: | Journal of cardiovascular pharmacology 1979-07, Vol.1 (4), p.395-402 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 402 |
|---|---|
| container_issue | 4 |
| container_start_page | 395 |
| container_title | Journal of cardiovascular pharmacology |
| container_volume | 1 |
| creator | Narahara, Kenneth A Singer, Jack W Ritchie, James L Williams, David L Hamilton, Glen W Kennedy, J Ward |
| description | Cardiac toxicity due to anthracycline therapy is dose related, and congestive failure is a major limiting factor to therapy. Radionuclide cardiac evaluation provides a sensitive noninvasive method for detecting changes in cardiac function. Fifteen patients receiving either doxorubicin or daunomycin were evaluated with radionuclide ejection fractions (EF). The data indicate that the EF can detect an acute depressant cardiac action of these drugs as early as 24 hr after drug administration. In addition, a cumulative or chronic cardiac depression was noted; cumulative dosage of doxorubicin or daunomycin correlated with a reduced EF (p < 0.001). We conclude that (1) the EF can noninvasively detect significant changes in cardiac function at low cumulative doses of doxorubicin or daunomycin and (2) the EF may be useful in evaluating cardiac function in patients during doxorubicin or daunomycin therapy. |
| doi_str_mv | 10.1097/00005344-197907000-00002 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00005344_197907000_00002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>94617</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3182-edb58613246818a80191c725a1e85dd0f4983eca35f3015d4c57ed595b0c3f893</originalsourceid><addsrcrecordid>eNp1kE1OwzAQhS1EBaVwAja-gMGO7cReVv0BpEoIqawj156QlNSJ7FRVb0_aQHfMZmbe0xtpPoQwo0-M6uyZ9iW5EITpTNOs38hJSq7QmEnOiaAJv0ZjylJKEiHSW3QX45ZSJmSW3qCRFinLxuhjXe2AYOMdnjcRyBxa8A58h2el8V8QceXxYgu2qxqPl8EMw7ToIOCp78peOdq68oDXJQTTHu_RqDB1hIffPkGfy8V69kpW7y9vs-mKWM5UQsBtpEoZT0SqmDKKMs1slkjDQEnnaCG04mANlwWnTDphZQZOarmhlhdK8wlSw10bmhgDFHkbqp0Jx5zR_IQo_0OUXxCdpaSPPg7Rdr_ZgbsEz0x6Vwzuoan7L-N3vT9AyEswdVfm_3HnPwbIb4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy</title><source>MEDLINE</source><source>Journals@Ovid LWW Legacy Archive</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Narahara, Kenneth A ; Singer, Jack W ; Ritchie, James L ; Williams, David L ; Hamilton, Glen W ; Kennedy, J Ward</creator><creatorcontrib>Narahara, Kenneth A ; Singer, Jack W ; Ritchie, James L ; Williams, David L ; Hamilton, Glen W ; Kennedy, J Ward</creatorcontrib><description>Cardiac toxicity due to anthracycline therapy is dose related, and congestive failure is a major limiting factor to therapy. Radionuclide cardiac evaluation provides a sensitive noninvasive method for detecting changes in cardiac function. Fifteen patients receiving either doxorubicin or daunomycin were evaluated with radionuclide ejection fractions (EF). The data indicate that the EF can detect an acute depressant cardiac action of these drugs as early as 24 hr after drug administration. In addition, a cumulative or chronic cardiac depression was noted; cumulative dosage of doxorubicin or daunomycin correlated with a reduced EF (p < 0.001). We conclude that (1) the EF can noninvasively detect significant changes in cardiac function at low cumulative doses of doxorubicin or daunomycin and (2) the EF may be useful in evaluating cardiac function in patients during doxorubicin or daunomycin therapy.</description><identifier>ISSN: 0160-2446</identifier><identifier>EISSN: 1533-4023</identifier><identifier>DOI: 10.1097/00005344-197907000-00002</identifier><identifier>PMID: 94617</identifier><language>eng</language><publisher>United States: Lippincott-Raven Publishers</publisher><subject>Adult ; Aged ; Daunorubicin - adverse effects ; Daunorubicin - therapeutic use ; Dose-Response Relationship, Drug ; Doxorubicin - adverse effects ; Doxorubicin - therapeutic use ; Female ; Heart Diseases - chemically induced ; Heart Diseases - physiopathology ; Humans ; Male ; Middle Aged ; Neoplasms - drug therapy ; Time Factors</subject><ispartof>Journal of cardiovascular pharmacology, 1979-07, Vol.1 (4), p.395-402</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3182-edb58613246818a80191c725a1e85dd0f4983eca35f3015d4c57ed595b0c3f893</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005344-197907000-00002$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4595,27901,27902,65206</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/94617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Narahara, Kenneth A</creatorcontrib><creatorcontrib>Singer, Jack W</creatorcontrib><creatorcontrib>Ritchie, James L</creatorcontrib><creatorcontrib>Williams, David L</creatorcontrib><creatorcontrib>Hamilton, Glen W</creatorcontrib><creatorcontrib>Kennedy, J Ward</creatorcontrib><title>Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy</title><title>Journal of cardiovascular pharmacology</title><addtitle>J Cardiovasc Pharmacol</addtitle><description>Cardiac toxicity due to anthracycline therapy is dose related, and congestive failure is a major limiting factor to therapy. Radionuclide cardiac evaluation provides a sensitive noninvasive method for detecting changes in cardiac function. Fifteen patients receiving either doxorubicin or daunomycin were evaluated with radionuclide ejection fractions (EF). The data indicate that the EF can detect an acute depressant cardiac action of these drugs as early as 24 hr after drug administration. In addition, a cumulative or chronic cardiac depression was noted; cumulative dosage of doxorubicin or daunomycin correlated with a reduced EF (p < 0.001). We conclude that (1) the EF can noninvasively detect significant changes in cardiac function at low cumulative doses of doxorubicin or daunomycin and (2) the EF may be useful in evaluating cardiac function in patients during doxorubicin or daunomycin therapy.</description><subject>Adult</subject><subject>Aged</subject><subject>Daunorubicin - adverse effects</subject><subject>Daunorubicin - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Doxorubicin - adverse effects</subject><subject>Doxorubicin - therapeutic use</subject><subject>Female</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - physiopathology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasms - drug therapy</subject><subject>Time Factors</subject><issn>0160-2446</issn><issn>1533-4023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1OwzAQhS1EBaVwAja-gMGO7cReVv0BpEoIqawj156QlNSJ7FRVb0_aQHfMZmbe0xtpPoQwo0-M6uyZ9iW5EITpTNOs38hJSq7QmEnOiaAJv0ZjylJKEiHSW3QX45ZSJmSW3qCRFinLxuhjXe2AYOMdnjcRyBxa8A58h2el8V8QceXxYgu2qxqPl8EMw7ToIOCp78peOdq68oDXJQTTHu_RqDB1hIffPkGfy8V69kpW7y9vs-mKWM5UQsBtpEoZT0SqmDKKMs1slkjDQEnnaCG04mANlwWnTDphZQZOarmhlhdK8wlSw10bmhgDFHkbqp0Jx5zR_IQo_0OUXxCdpaSPPg7Rdr_ZgbsEz0x6Vwzuoan7L-N3vT9AyEswdVfm_3HnPwbIb4w</recordid><startdate>197907</startdate><enddate>197907</enddate><creator>Narahara, Kenneth A</creator><creator>Singer, Jack W</creator><creator>Ritchie, James L</creator><creator>Williams, David L</creator><creator>Hamilton, Glen W</creator><creator>Kennedy, J Ward</creator><general>Lippincott-Raven Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>197907</creationdate><title>Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy</title><author>Narahara, Kenneth A ; Singer, Jack W ; Ritchie, James L ; Williams, David L ; Hamilton, Glen W ; Kennedy, J Ward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3182-edb58613246818a80191c725a1e85dd0f4983eca35f3015d4c57ed595b0c3f893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Daunorubicin - adverse effects</topic><topic>Daunorubicin - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Doxorubicin - adverse effects</topic><topic>Doxorubicin - therapeutic use</topic><topic>Female</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - physiopathology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasms - drug therapy</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Narahara, Kenneth A</creatorcontrib><creatorcontrib>Singer, Jack W</creatorcontrib><creatorcontrib>Ritchie, James L</creatorcontrib><creatorcontrib>Williams, David L</creatorcontrib><creatorcontrib>Hamilton, Glen W</creatorcontrib><creatorcontrib>Kennedy, J Ward</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of cardiovascular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Narahara, Kenneth A</au><au>Singer, Jack W</au><au>Ritchie, James L</au><au>Williams, David L</au><au>Hamilton, Glen W</au><au>Kennedy, J Ward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy</atitle><jtitle>Journal of cardiovascular pharmacology</jtitle><addtitle>J Cardiovasc Pharmacol</addtitle><date>1979-07</date><risdate>1979</risdate><volume>1</volume><issue>4</issue><spage>395</spage><epage>402</epage><pages>395-402</pages><issn>0160-2446</issn><eissn>1533-4023</eissn><abstract>Cardiac toxicity due to anthracycline therapy is dose related, and congestive failure is a major limiting factor to therapy. Radionuclide cardiac evaluation provides a sensitive noninvasive method for detecting changes in cardiac function. Fifteen patients receiving either doxorubicin or daunomycin were evaluated with radionuclide ejection fractions (EF). The data indicate that the EF can detect an acute depressant cardiac action of these drugs as early as 24 hr after drug administration. In addition, a cumulative or chronic cardiac depression was noted; cumulative dosage of doxorubicin or daunomycin correlated with a reduced EF (p < 0.001). We conclude that (1) the EF can noninvasively detect significant changes in cardiac function at low cumulative doses of doxorubicin or daunomycin and (2) the EF may be useful in evaluating cardiac function in patients during doxorubicin or daunomycin therapy.</abstract><cop>United States</cop><pub>Lippincott-Raven Publishers</pub><pmid>94617</pmid><doi>10.1097/00005344-197907000-00002</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0160-2446 |
| ispartof | Journal of cardiovascular pharmacology, 1979-07, Vol.1 (4), p.395-402 |
| issn | 0160-2446 1533-4023 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_00005344_197907000_00002 |
| source | MEDLINE; Journals@Ovid LWW Legacy Archive; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
| subjects | Adult Aged Daunorubicin - adverse effects Daunorubicin - therapeutic use Dose-Response Relationship, Drug Doxorubicin - adverse effects Doxorubicin - therapeutic use Female Heart Diseases - chemically induced Heart Diseases - physiopathology Humans Male Middle Aged Neoplasms - drug therapy Time Factors |
| title | Time- and Dose-Dependent Changes in Ejection Fraction After Anthracycline Therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A39%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time-%20and%20Dose-Dependent%20Changes%20in%20Ejection%20Fraction%20After%20Anthracycline%20Therapy&rft.jtitle=Journal%20of%20cardiovascular%20pharmacology&rft.au=Narahara,%20Kenneth%20A&rft.date=1979-07&rft.volume=1&rft.issue=4&rft.spage=395&rft.epage=402&rft.pages=395-402&rft.issn=0160-2446&rft.eissn=1533-4023&rft_id=info:doi/10.1097/00005344-197907000-00002&rft_dat=%3Cpubmed_cross%3E94617%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/94617&rfr_iscdi=true |